|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the CVS 10-Q filed May 8, 2007. Impairment of Long-Lived Assets We account for the impairment of long-lived assets in accordance with SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As such, we evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset group to the individual stores estimated future cash flows (undiscounted and without interest charges).
28
Table of Contents
Managements Discussion and Analysis of Financial Condition and Results of Operations If the estimated future cash flows are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset groups carrying value that exceeds the individual stores estimated future cash flows (discounted and with interest charges). Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. The net book value of our long-lived assets, including intangible assets with finite lives, covered by this critical accounting policy was approximately $9 billion as of March 31, 2007. During 2006, 2005 and 2004, we recorded pre-tax impairment losses totaling $28 million, $27 million and $20 million, respectively. Although we believe we have sufficient current and historical information available to us to record reasonable estimates for impairment losses, it is possible that actual results could differ. In order to help you assess the risk, if any, associated with the uncertainties discussed above, we believe the $8 million pre-tax difference between the high and low end of the three-year impairment loss range would be a reasonably likely annual increase or decrease in the impairment of long-lived assets. We have not made any material changes to our impairment loss assessment methodology during the past three years. This excerpt taken from the CVS 10-K filed Feb 27, 2007. Impairment of long-lived assets ~
The Company accounts for the impairment of long-lived assets in accordance with
SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As
such, the Company groups and evaluates fixed and finite-lived intangible assets
excluding goodwill, for impairment at the individual store level, which is the
lowest level at which individual cash flows can be identified. When evaluating
assets for potential impairment, the Company first compares the carrying amount
of the asset group to the individual stores estimated future cash flows
(undiscounted and without interest charges). If the estimated future cash flows
used in this analysis are less than the carrying amount of the asset group, an
impairment loss calculation is prepared. The impairment loss calculation
compares the carrying amount of the asset group to the individual stores
estimated fair value based on estimated future cash flows (discounted and with
interest charges). If the carrying amount exceeds the individual stores
estimated future cash flows (discounted and with interest charges), the loss is
allocated to the long-lived assets of the group on a pro rata basis using the
relative carrying amounts of those assets.
This excerpt taken from the CVS 10-Q filed Nov 3, 2006. Impairment of Long-Lived Assets We account for the impairment of long-lived assets in accordance with SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As such, we evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset group to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset groups carrying value that exceeds the individual stores estimated future cash flows (discounted and with interest charges). Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. The net book value of our long-lived assets, including intangible assets with finite lives, covered by this critical accounting policy was approximately $7.5 billion as of September 30, 2006. During 2005, 2004 and 2003, we recorded pre-tax impairment losses totaling $27 million, $20 million and $22 million, respectively. Although we believe we have sufficient current and historical information available to us to record reasonable estimates for impairment losses, it is possible that actual results could differ. In order to help you assess the risk, if any, associated with the uncertainties discussed above, we believe the $7 million pre-tax difference between the high and low end of the three-year impairment loss range would be a reasonably likely annual increase or decrease in the impairment of long-lived assets. We have not made any material changes to our impairment loss assessment methodology or impairment loss estimates during the past three years. This excerpt taken from the CVS 10-Q filed Aug 8, 2006. Impairment of Long-Lived Assets We account for the impairment of long-lived assets in accordance with SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As such, we evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset group to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset groups carrying value that exceeds the individual stores estimated future cash flows (discounted and with interest charges). Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. The net book value of our long-lived assets, including intangible assets with finite lives, covered by this critical accounting policy was approximately $7 billion as of July 1, 2006. During 2005, 2004 and 2003, we recorded pre-tax impairment losses totaling $27 million, $20 million and $22 million, respectively. Although we believe we have sufficient current and historical information available to us to record reasonable estimates for impairment losses, it is possible that actual results could differ. In order to help you assess the risk, if any, associated with the uncertainties discussed above, we believe the $7 million pre-tax difference between the high and low end of the three-year impairment loss range would be a reasonably likely annual increase or decrease in the impairment of long-lived assets. We have not made any material changes to our impairment loss assessment methodology or impairment loss estimates during the past three years. This excerpt taken from the CVS 8-K filed Aug 8, 2006. Impairment of Long-Lived Assets The Business regularly reviews its stores and other long-lived assets and asset groups for indicators of impairment based on operational performance and the Business plans for store closures. When events or changes in circumstances indicate that the carrying value of an asset or an asset group may not be recoverable, the assets fair value is compared to its carrying value. Impairment losses are recognized as the amount by which the carrying amounts of the assets exceed their fair values. Asset fair values are determined by internal real estate specialists or by independent valuation experts. These estimates can be significantly impacted by factors such as changes in real estate market conditions, the economic environment and inflation. The Business recognized impairment charges related to assets sold to CVS of $1 for the 52 weeks ended February 2, 2006. This charge was recorded in Selling, general and administrative expenses in the accompanying Statement of Revenues and Direct Expenses. There were no impairment charges recorded for the 13-week periods ended May 4, 2006 and May 5, 2005, respectively. This excerpt taken from the CVS 8-K filed Jun 30, 2006. Impairment of Long-Lived Assets The Business regularly reviews its stores and other long-lived assets and asset groups for indicators of impairment based on operational performance and the Business plans for store closures. When events or changes in circumstances indicate that the carrying value of an asset or an asset group may not be recoverable, the assets fair value is compared to its carrying value. Impairment losses are recognized as the amount by which the carrying amounts of the assets exceed their fair values. Asset fair values are determined by internal real estate specialists or by independent valuation experts. These estimates can be significantly impacted by factors such as changes in real estate market conditions, the economic environment and inflation. The Business recognized impairment charges related to assets sold to CVS of $1 for the 52 weeks ended February 2, 2006. This charge was recorded in Selling, general and administrative expenses in the accompanying Statement of Revenues and Direct Expenses. There were no impairment charges recorded for the 13-week periods ended May 4, 2006 and May 5, 2005, respectively. This excerpt taken from the CVS 10-Q filed May 9, 2006. Impairment of Long-Lived Assets We account for the impairment of long-lived assets in accordance with SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As such, we evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset group to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset groups carrying value that exceeds the individual stores estimated future cash flows (discounted and with interest charges). Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. We have not made any material changes to our impairment loss assessment methodology during the past three years.
20
Table of Contents
Managements Discussion and Analysis of Financial Condition and Results of Operations This excerpt taken from the CVS 10-K filed Mar 14, 2006. Impairment of Long-Lived Assets We account for the impairment of long-lived assets in accordance with Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. As such, we evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows
21
can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset group to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset groups carrying value that exceeds the individual stores estimated future cash flows (discounted and with interest charges). Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. We have not made any material changes to our impairment loss assessment methodology during the past three years. This excerpt taken from the CVS 10-Q filed Nov 3, 2005. Impairment of Long-Lived Assets
We evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the assets carrying value that exceeds the assets estimated future cash flow (discounted and with interest charges).
17
Table of Contents
Managements Discussion and Analysis of Financial Condition and Results of Operations
Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. We have not made any material changes to our impairment loss assessment methodology during the past three years.
This excerpt taken from the CVS 10-Q filed Aug 9, 2005. Impairment of Long-Lived Assets
We evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the assets carrying value that exceeds the assets estimated future cash flow (discounted and with interest charges).
16
Table of Contents
Managements Discussion and Analysis of Financial Condition and Results of Operations
Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. We have not made any material changes to our impairment loss assessment methodology during the past three years.
This excerpt taken from the CVS 10-Q filed May 9, 2005. Impairment of Long-Lived Assets
We evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the assets carrying value that exceeds the assets estimated future cash flow (discounted and with interest charges).
Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. We have not made any material changes to our impairment loss assessment methodology during the past three years.
This excerpt taken from the CVS 10-K filed Mar 16, 2005. Impairment of Long-Lived Assets
We evaluate the recoverability of long-lived assets, including intangible assets with finite lives, but excluding goodwill, which is tested for impairment using a separate test, annually or whenever events or changes in circumstances indicate that
22
the carrying value of an asset may not be recoverable. We group and evaluate long-lived assets for impairment at the individual store level, which is the lowest level at which individual cash flows can be identified. When evaluating long-lived assets for potential impairment, we first compare the carrying amount of the asset to the individual stores estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the individual stores estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the assets carrying value that exceeds the assets estimated future cash flow (discounted and with interest charges).
Our impairment loss calculation contains uncertainty since we must use judgment to estimate each stores future sales, profitability and cash flows. When preparing these estimates, we consider each stores historical results and current operating trends and our consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited to, general economic conditions, the cost of real estate, the continued efforts of third party organizations to reduce their prescription drug costs, the continued efforts of competitors to gain market share and consumer spending patterns. Effective for fiscal 2002, we adopted Statement of Financial Accounting Standards (SFAS) No. 144 Accounting for Impairment or Disposal of Long-Lived Assets. The adoption did not have a material impact on our impairment loss methodology and we have not made any other material changes to our impairment loss assessment methodology during the past three years.
| EXCERPTS ON THIS PAGE:
|
| |||||||